Mounjaro®
Starting from £179.99/mo
Start journey Learn moreReduced appetite is one of the most common experiences on Mounjaro. Tirzepatide activates GIP and GLP-1 receptors that regulate hunger signals, which means many people find food simply stops being appealing — sometimes dramatically so. That shift is central to how the treatment works, but it also raises a practical decision: when appetite falls away, what and how much should you actually eat? These are prescription-only medicines; a GPhC-registered prescriber reviews your case before treatment starts, and any significant concerns about eating during treatment should go back to them. What follows is a factual guide to what the NHS Mounjaro medicines page describes as expected, and how to approach it sensibly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people starting Mounjaro notice some change in appetite fairly quickly. Tirzepatide works partly by slowing how fast food leaves the stomach, so you feel full sooner and stay that way longer, and our page on how tirzepatide affects appetite explains the underlying mechanisms in more detail. What varies is how pronounced that feeling gets. A noticeable drop in appetite (eating smaller portions, skipping a snack you'd normally have, feeling satisfied after half a plate) sits well within the expected range described in the prescribing information.
A harder question is where 'expected' ends and 'worth flagging' begins. If you're genuinely struggling to eat more than a small amount across the day, or food has become actively repellent rather than simply less appealing, that's a different situation. The complete loss of appetite on Mounjaro can happen, and it is something a prescriber should know about, not because it means stopping treatment, but because they may want to review your dose timing or titration pace.
Nausea compounds the picture. The two often travel together, particularly in the days after moving to a higher dose. Most people find this settles within a fortnight. Eating smaller, blander meals, avoiding high-fat or spicy food, and not lying down straight after eating can all help. If nausea is severe or prolonged, contact your prescribing team. At nume, clinical support is available seven days a week via our aftercare team.
There's a temptation, when appetite drops sharply, to simply let it. Weight is falling, hunger isn't there, why force anything? The issue is that significant calorie restriction without adequate protein accelerates the loss of lean muscle mass alongside fat. That matters both for how you feel now and for your metabolic health long term.
UK guidance on weight management (including NHS England's wraparound care framework for weight-loss medicines) consistently emphasises maintaining protein intake and, where possible, some form of resistance activity. Even on a reduced appetite, aiming for a spread of protein across meals (eggs, fish, chicken, pulses, dairy) rather than eating whatever's easiest keeps muscle better protected.
Hydration is the other common gap. People who eat less also often drink less, and mild dehydration worsens fatigue and headaches that can themselves be mistaken for hunger signals. A water bottle on the desk or beside the kettle in the morning is a simple prompt. For a more detailed look at what to prioritise on the plate, our food guide for people on Mounjaro covers protein targets, fibre, and meal timing in practical terms.
The reverse experience also happens. Some people start treatment expecting appetite to vanish immediately and find it doesn't, or notice suppression fades at certain points in the week. If you want to understand the mechanics behind this, our page on whether Mounjaro suppresses appetite explains how the drug interacts with hunger hormones and why the effect can feel inconsistent. This doesn't mean the medicine isn't working; weight reduction and appetite suppression don't always run at the same pace.
If you've been on treatment for several weeks at a stable dose and feel no appetite change at all, that is worth raising with your prescriber before assuming you need a dose increase. There's a difference between appetite suppression that's subtler than you expected and Mounjaro not suppressing appetite in any meaningful way, the latter is genuinely less common and may warrant a clinical conversation about whether the current dose or titration pace is right for you.
Cost and continuity sometimes factor into these decisions too. If you're thinking about the longer picture (how treatment is priced, what's included) our weight-loss treatments page sets out what a private prescription through a regulated service covers.
One of the more disorienting things about Mounjaro is that it removes the normal cue you'd use to decide when and how much to eat. Hunger has always been the default prompt. When it fades, some people under-eat; others, finding meals less satisfying, make poor food choices because nothing appeals anyway.
A practical response is to shift from appetite-led eating to a loose structure: three modest meals, protein at each, and a glass of water before sitting down. It doesn't need to be a rigid plan, just a scaffold while the appetite signal recalibrates. The Mounjaro overview page has a fuller picture of how treatment works and what to expect across the weeks of titration.
If this is something you're navigating now and you haven't yet spoken to a prescriber about your full history, exploring treatment options with a clinical team is a reasonable first step. A prescriber who understands your baseline can give much more specific guidance than any general article can.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.